Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: Dsstox_cid_25883, Dsstox_rid_81198, Dsstox_gsid_45883, 1-[(3ar,5r,6s,6ar)-6-[3-(dimethylamino)propoxy]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol;hydrochloride, Sr-01000075667, Ncgc00095000-01
Molecular Formula
C14H28ClNO6
Molecular Weight
341.83  g/mol
InChI Key
RJNRORZRFGUAKL-VPHFYIDPSA-N

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-[(3aR,5R,6S,6aR)-6-[3-(dimethylamino)propoxy]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol;hydrochloride
2.1.2 InChI
InChI=1S/C14H27NO6.ClH/c1-14(2)20-12-11(18-7-5-6-15(3)4)10(9(17)8-16)19-13(12)21-14;/h9-13,16-17H,5-8H2,1-4H3;1H/t9?,10-,11+,12-,13-;/m1./s1
2.1.3 InChI Key
RJNRORZRFGUAKL-VPHFYIDPSA-N
2.1.4 Canonical SMILES
CC1(OC2C(C(OC2O1)C(CO)O)OCCCN(C)C)C.Cl
2.1.5 Isomeric SMILES
CC1(O[C@@H]2[C@H]([C@H](O[C@@H]2O1)C(CO)O)OCCCN(C)C)C.Cl
2.2 Synonyms
2.2.1 MeSH Synonyms

1. 1,2-o-isopropylidene-3-o-3'-(n',n'-dimethylamino-n-propyl)-d-glucofuranose

2. 3-o-(3-(dimethylamino)propyl)-1,2-o-(1-methylethylidene)- Alpha-d-glucofuranose

3. Amiprilose

4. Amprilose

5. Sm 1213

6. Sm-1213

7. Therafectin

2.2.2 Depositor-Supplied Synonyms

1. Dsstox_cid_25883

2. Dsstox_rid_81198

3. Dsstox_gsid_45883

4. 1-[(3ar,5r,6s,6ar)-6-[3-(dimethylamino)propoxy]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol;hydrochloride

5. Sr-01000075667

6. Ncgc00095000-01

7. Cas-60414-06-4

8. Schembl41474

9. Chembl3184686

10. Dtxsid5045883

11. Tox21_111382

12. Tox21_111382_1

13. Lp00047

14. Ncgc00162052-05

15. Eu-0100047

16. A 4687

17. Sr-01000075667-1

18. Sr-01000075667-5

19. 1,2-o-isopropylidene-3-o-[3'-(n,n-dimethylamino)propyl]-alpha-d-glucofuranose Hydrochloride

2.3 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 341.83 g/mol
Molecular Formula C14H28ClNO6
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count7
Rotatable Bond Count7
Exact Mass341.1605153 g/mol
Monoisotopic Mass341.1605153 g/mol
Topological Polar Surface Area80.6 Ų
Heavy Atom Count22
Formal Charge0
Complexity337
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Inflammatory Agents, Non-Steroidal

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)


Adjuvants, Immunologic

Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)


Antiviral Agents

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)